Malaria is a preventable and treatable parasitic disease, but diagnosing it can be a challenge in the developing countries where it’s most prevalent. Thus, the demand remains for a more effective, less expensive, and accurate point-of-care diagnostic diagnostics test. IV Lab’s engineers and scientists, as part of IV’s Global Good program, seek to develop more effective, less expensive, and accurate malaria diagnostic techniques.
Food safety and agricultural productivity are issues that can limit the quality of life in the developing world. In many developing countries, milk is a significant source of calories, macronutrients, vitamins, and minerals in the human diet. In an effort to increase incomes for small-scale farmers and to increase the supply of safe milk, IV Lab in partnership with Global Good is developing alternative milk transportation systems for use in rural areas of the developing world. Our goal is to invent a system that helps rural dairy farmers maximize the quantity and quality of milk they’re able to market and sell.
With drug resistance spreading and nearly one third of the world’s population harboring asymptomatic infections, TB has the potential to become a global health crisis. TB is a challenging disease to manage because it is slow and costly to diagnose and takes several months of strict drug regimens to treat. Our team of engineers and chemists are working to develop a novel method for concentrating and capturing bacteria from sputum that provides high sensitivity and a greatly simplified user-experience for lab technicians.
One way to break the malaria transmission cycle is to prevent the primary vector – the female Anopheles mosquito – from reaching the age where it can infect a healthy host. We are developing a device capability of identifying the discriminating characteristics of a mosquito (wing beat frequency, shape, size, airspeed, etc.), training a laser on it, and delivering adequate photonic energy to kill or incapacitate it.
Diseases like polio have been eradicated in many countries through vaccination, however, they are still prominent in large parts of the developing world. One of the greatest challenges to vaccination in remote areas is the cold chain, vaccines must be kept at precise temperatures until use to prevent spoiling. We are developing an insulated container to strengthen vaccination services in developing countries which is designed to keep vaccines at the appropriate temperatures for a month or more.